Cargando…

Tolerance and rebound with zafirlukast in patients with persistent asthma

BACKGROUND: The potential for tolerance to develop to zafirlukast, a cysteinyl leukotriene (CysLT) receptor antagonist (LRA) in persistent asthma, has not been specifically examined. OBJECTIVE: To look for any evidence of tolerance and potential for short-term clinical worsening on LRA withdrawal. O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reid, David W, Misso, Neil L, Aggarwal, Shashi, Thompson, Philip J, Johns, David P, Walters, E Haydn
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2426667/ https://www.ncbi.nlm.nih.gov/pubmed/18489783 http://dx.doi.org/10.1186/1477-5751-7-3

Ejemplares similares

Does zafirlukast reduce future risk of asthma exacerbations in adults? Systematic review and meta-analysis
por: Chen, Chao Feng, et al.
Publicado: (2014)

Zafirlukast Is a Promising Scaffold for Selectively Inhibiting TNFR1 Signaling
por: Vunnam, Nagamani, et al.
Publicado: (2023)

Synthesis of Asthma Drug Zafirlukast (Accolate) Using Intramolecular Oxidative Coupling via sp(3) C–H Bond Activation
por: Paladugu, Srinu, et al.
Publicado: (2018)

Effect of Zafirlukast on improving lung function in patients with chronic obstructive pulmonary diseases
por: Moosavi, Seyed Ali Javad, et al.
Publicado: (2013)

The Preventive Effect of Topical Zafirlukast Instillation for Peri-Implant Capsule Formation in Rabbits
por: Kang, Shin Hyuk, et al.
Publicado: (2015)

Zafirlukast in combination with pseudohypericin attenuates spinal cord injury and motor function in experimental mice
por: Chen, Xiao-Gang, et al.
Publicado: (2018)

Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast
por: Schierle, Simone, et al.
Publicado: (2019)

AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate()
por: Delijewski, Marcin, et al.
Publicado: (2021)

To rebound or not to rebound
por: Stahl, Bethany A, et al.
Publicado: (2017)

Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity
por: Shi, Sai, et al.
Publicado: (2022)

Zafirlukast in Combination with Pseudohypericin Attenuates Spinal Cord Injury and Motor Function in Experimental Mice [Corrigendum]
Publicado: (2021)

Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ
por: Göbel, Tamara, et al.
Publicado: (2019)

Zafirlukast is a broad‐spectrum thiol isomerase inhibitor that inhibits thrombosis without altering bleeding times
por: Holbrook, Lisa‐Marie, et al.
Publicado: (2021)

Mobile Technology Interventions for Asthma Self-Management: Systematic Review and Meta-Analysis
por: Miller, Lisa, et al.
Publicado: (2017)

Age-dependent rebound in asthma exacerbations after COVID-19 lockdown
por: Hazan, Guy, et al.
Publicado: (2022)

Gastroprotective effect of zafirlukast against indomethacin induced gastric ulcer in rats via PGE2 and anti-inflammatory pathways
por: Aal-Aaboda, Munaf, et al.
Publicado: (2023)

Distinctive characteristics of bronchial reticular basement membrane and vessel remodelling in chronic obstructive pulmonary disease (COPD) and in asthma: they are not the same disease
por: Soltani, Amir, et al.
Publicado: (2012)

Zafirlukast Induces VHL- and HIF-2α-Dependent Oxidative Cell Death in 786-O Clear Cell Renal Carcinoma Cells
por: Wolf, Christopher, et al.
Publicado: (2022)

Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal
por: Koska, Valeria, et al.
Publicado: (2021)

Effects of the Demethylating Agent, 5-Azacytidine, on Expression of the Kallikrein-Kinin Genes in Carcinoma Cells of the Lung and Pleura
por: Wong, Joshua, et al.
Publicado: (2011)

A multidimensional HIV-1 persistence model for clonal expansion and viral rebound in vitro
por: Eshetu, Amare, et al.
Publicado: (2021)

Zafirlukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Reduces the Effect of Advanced Glycation End-Products in Rat Renal Mesangial Cells In Vitro
por: Yan, Liping, et al.
Publicado: (2019)

Blockade of Platelet CysLT1R Receptor with Zafirlukast Counteracts Platelet Protumoral Action and Prevents Breast Cancer Metastasis to Bone and Lung
por: Saier, Lou, et al.
Publicado: (2022)

Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK)
por: Tydeman, Florence, et al.
Publicado: (2023)

Clinical trial of community nurse mentoring to improve self-management in patients with chronic obstructive pulmonary disease
por: Wood-Baker, Richard, et al.
Publicado: (2012)

Zafirlukast ameliorates Docetaxel-induced activation of NOD-like receptor protein 3 (NLRP3) inflammasome, mediated by sirtuin1 (SIRT1) in hepatocytes
por: Guo, Ziyi, et al.
Publicado: (2021)

The efficacy of Zafirlukast as a SARS-CoV-2 helicase inhibitor in adult patients with moderate COVID-19 Pneumonia (pilot randomized clinical trial)
por: Ghobain, M.Al, et al.
Publicado: (2022)

Natalizumab Rebound in Multiple Sclerosis
por: Lee, Joshua D., et al.
Publicado: (2021)

Rebound and Spillovers: Prosumers in Transition
por: Dütschke, Elisabeth, et al.
Publicado: (2021)

Dopamine Rebound-Excitation Theory: Putting Brakes on PTSD
por: Lee, Jason C., et al.
Publicado: (2016)

Current asthma contributes as much as smoking to chronic bronchitis in middle age: a prospective population-based study
por: Dharmage, Shyamali C, et al.
Publicado: (2016)

Albuterol enantiomer levels, lung function and QTc interval in patients with acute severe asthma and COPD in the emergency department
por: Yee, Kwang Choon, et al.
Publicado: (2011)

Bronchodilator reversibility as a diagnostic test for adult asthma: findings from the population-based Tasmanian Longitudinal Health Study
por: Tan, Daniel J., et al.
Publicado: (2021)

Novel Methodology for Football Rebound Test Method
por: Colino, Enrique, et al.
Publicado: (2020)

Viral and Symptom Rebound in Untreated COVID-19 Infection
por: Deo, Rinki, et al.
Publicado: (2022)

Hepatitis Rebound after Infection with Yellow Fever Virus
por: Denis, Blandine, et al.
Publicado: (2019)

The influence of interparticle cohesion on rebounding slow impacts on rubble pile asteroids
por: Joeris, Kolja, et al.
Publicado: (2022)

Pandemics and the Environmental Rebound Effect: Reflections from COVID-19
por: Freire-González, Jaume, et al.
Publicado: (2020)

Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD
por: Wen, Yudong, et al.
Publicado: (2010)

Comparison of three rebound tonometers in normal and glaucomatous dogs
por: Hodgson, Kimberly J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c441km6jqpcun8tfji1q1nr191